Profile
DHR-PB TMO DHR IDXX A IQV
Company Name Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc. IQVIA Holdings Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $916.76B $160.15B $141.09B $35.45B $30.30B $26.50B
Employees 79.00K 125.00K 61.00K 11.00K 17.90K 88.00K
CEO Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Jonathan J. Mazelsky Mr. Padraig McDonnell Mr. Ari Bousbib
Ratings
DHR-PB TMO DHR IDXX A IQV
Quant Rating Score 5 3 3 3 3 3
Quant Rating Strong Buy Neutral Neutral Neutral Neutral Neutral
Trading
DHR-PB TMO DHR IDXX A IQV
Last Close $1261.26 $424.24 $197.14 $437.44 $106.28 $150.28
High 52 $1261.26 $624.21 $280.76 $548.53 $154.64 $251.55
Low 52 $1261.26 $419.59 $174.64 $361.04 $99.29 $141.22
Price vs. 52 Week High 0 % -32.04 % -29.78 % -20.25 % -31.27 % -40.26 %
Price vs. 52 Week Low 0 % 1.11 % 12.88 % 21.16 % 7.04 % 6.42 %
Total Return
DHR-PB TMO DHR IDXX A IQV
1 Month Return 0 % -17.05 % -6.14 % 3.53 % -10.67 % -16.21 %
3 Month Return 0 % -27.31 % -21.33 % 2.32 % -29.6 % -27.4 %
6 Month Return 0 % -23.47 % -19.66 % -3.09 % -18.37 % -29.98 %
9 Month Return 0 % -30.12 % -28.03 % -6.87 % -22.6 % -37.3 %
YTD Return 0 % -18.45 % -14.12 % 5.8 % -20.89 % -23.53 %
1 Year Return 0 % -26.04 % -20.05 % -12.39 % -22.84 % -36.02 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DHR-PB TMO DHR IDXX A IQV
Dividend Yield Percentage (TTM) 0.57 % 0.38 % 0.57 % - 0.91 % -
Dividend Paid and Capex Coverage Ration (TTM) 2.93 % 4.05 % 2.93 % 7.1 % 3.01 % 4.51 %
Dividend Per Share (TTM) 1.13 % 1.6 % 1.13 % - 0.97 % -
Payout Ratio (TTM) 20.85 % 9.16 % 20.85 % - 21.92 % -
Growth
DHR-PB TMO DHR IDXX A IQV
Asset Growth -8.22 % -1.42 % -8.22 % 1.03 % 10.06 % 0.82 %
Gross Profit Growth 1.23 % 5.81 % 1.23 % 8.63 % 2.02 % 2.6 %
Revenue Growth -0.06 % 0.05 % -0.06 % 6.46 % -4.73 % 2.81 %
Revenue 3 Year -21.41 % 12.79 % -21.41 % 25.48 % 8 % 17.22 %
Revenue 5 Year 29.31 % 75.79 % 29.31 % 69.43 % 36.52 % 49.51 %
Revenue 10 Year 14.22 % 164.64 % 14.22 % 219.02 % 7.08 % 99.19 %
EBIT Growth -6.52 % 6.97 % -6.52 % 2.84 % 10.22 % 11.38 %
Net Income Growth -18.16 % 5.67 % -18.16 % 5.07 % 3.95 % 1.1 %
Net Income 3 Yeari Growth Per Share -41.24 % -15.42 % -41.24 % 23.4 % 11.67 % 50.05 %
Net Income 5 Yeari Growth Per Share 25.73 % 79.48 % 25.73 % 117.19 % 30.32 % 673.56 %
Net Income 10 Yeari Growth Per Share 42.96 % 248.59 % 42.96 % 493.59 % 197.81 % 171.99 %
Operating Income Growth -6.52 % 6.97 % -6.52 % 2.84 % 10.22 % 11.38 %
Operating Cash Flow Growth (CFG) -6.64 % 3.1 % -6.64 % 2.48 % -1.19 % 26.38 %
Operating 3 Year CFG -22.42 % -6.33 % -22.42 % 27.28 % 23.6 % -2.54 %
Operating 5 Year CFG 64.18 % 82.49 % 64.18 % 111.7 % 85.69 % 106.26 %
Operating 10 Year CFG 69.53 % 244.88 % 69.53 % 379.04 % 182 % 344.1 %
EPS Growth -17.86 % 6.76 % -17.86 % 6.1 % 5.21 % 2.44 %
EPS Diluted Growth -17.08 % 7.06 % -17.08 % 6.26 % 5.73 % 2.74 %
Book Value Per Share -7.44 % 7.15 % -7.44 % 8.46 % 2.3 % 0.63 %
Share Holder 3 Year Equity Growth Per Share 6.35 % 25.29 % 6.35 % 139.34 % 14.73 % 6.01 %
Share Holder 5 Year Equity Growth Per Share 58.77 % 74.85 % 58.77 % 840.53 % 34.5 % 8.76 %
Share Holder 10 Year Equity Growth Per Share 101.9 % 151.37 % 101.9 % 1550.96 % 27.76 % 708.4 %
Dividend Per Share Growth -6.53 % 12.64 % -6.53 % - 4.82 % -
Dividend 3 Year Growth Per Share 0.35 % 52.23 % 0.35 % - 21.71 % -
Dividend 5 Year Growth Per Share 41.45 % 105.55 % 41.45 % - 44.02 % -
Dividend 10 Year Growth Per Share 221.34 % 158.83 % 221.34 % - 78.77 % -
Debt Growth -18.07 % -10.43 % -18.07 % -7.53 % 23.95 % -90.74 %
Free Cash Flow Growth -8.39 % 4.91 % -8.39 % 3.26 % -6.85 % 81.07 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Oct 2024 31 Dec 2024
Profitability
DHR-PB TMO DHR IDXX A IQV
Gross Profit Margin TTM 59.74 % 41.74 % 59.74 % 61.08 % 53.97 % 31.44 %
Return on Assets TTM 4.76 % 6.58 % 4.76 % 26.96 % 10.57 % 5.1 %
Return on Equity TTM 7.47 % 13.34 % 7.47 % 55.82 % 20.95 % 21.05 %
Return on Capital Employed TTM 6.66 % 8.53 % 6.66 % 50.78 % 14.73 % 11.27 %
Net Income Per EBT TTM 83.59 % 92.18 % 83.59 % 80 % 84.78 % 82.26 %
EBT Per Ebit TTM 93.35 % 96.45 % 93.35 % 98.21 % 100.34 % 74.24 %
EBIT Per Revenue TTM 20.26 % 17.08 % 20.26 % 28.99 % 22.65 % 14.59 %
Cash Flow To Debt Ratio TTM 37.92 % 23.81 % 37.92 % 94.13 % 50.46 % 206.07 %
Receivables Turnover TTM 6.79 5.07 6.79 6.94 4.92 4.06
Payables Turnover TTM 5.57 - 5.57 13.28 5.5 14.35
Inventory Turnover TTM 3.79 4.78 3.79 3.97 3.02 -
Fixed Asset Turnover TTM 466.14 % 459.74 % 466.14 % 470 % 359.75 % 1993.27 %
Asset Turnover TTM 30.11 % 43.31 % 30.11 % 118.34 % 54.83 % 57.28 %
Operating Cash Flow Per Share TTM 8.72 21.53 8.72 11.29 5.95 14.98
Free Cash Flow Per Share TTM 6.84 17.79 6.84 9.7 4.94 11.66
Cash Per Share TTM 278.24 % 1573.28 % 278.24 % 350.25 % 514.74 % 1016.55 %
Operating Cash Flow Sales Ratio TTM 26.23 % 18.97 % 26.23 % 23.84 % 25.98 % 17.63 %
Free Cash Flow Operating Cash Flow Ratio TTM 78.46 % 82.61 % 78.46 % 85.91 % 83.03 % 77.84 %
Cash Flow Coverage Ratios TTM 37.92 % 23.81 % 37.92 % 94.13 % 50.46 % 206.07 %
Price To Free Cash Flows Ratio TTM 28.78 23.82 28.78 44.42 21.51 12.53
Price To Operating Cash Flows Ratio TTM 22.6 19.7 22.6 38.75 17.85 10.03
Price Cash Flow Ratio TTM 22.6 19.7 22.6 38.75 17.85 10.03
Income Statement (TTM)
DHR-PB TMO DHR IDXX A IQV
Revenue $23.88B $42.88B $23.88B $3.9B $6.51B $15.41B
Gross Profit $14.21B $18.11B $14.21B $2.38B $3.54B $5.38B
Gross Profit Ratio 59.5% 42.23% 59.5% 61.04% 54.3% 34.89%
EBITDA $4.86B $11.54B $4.86B $1.27B $1.49B $3.45B
Net Income $3.9B $6.34B $3.9B $0.89B $1.29B $1.37B
EPS Diluted 5.29 16.53 5.29 10.67 4.43 7.49
Balance Sheet (MRQ)
DHR-PB TMO DHR IDXX A IQV
Long Term Debt $15.5B $29.06B $15.5B $0.55B $3.35B $0.35B
Total Liabilities $27.99B $47.65B $27.99B $1.7B $5.95B $20.83B
Total Equity $49.55B $49.67B $49.55B $1.6B $5.9B $6.07B
Total Investments $0B $1.56B $0B $0.06B $0.18B $0.11B
Total Debt $16.01B $31.28B $16.01B $0.99B $3.39B $1.32B
Total Assets $77.54B $97.32B $77.54B $3.29B $11.85B $26.9B
Cash Flow Statement (TTM)
DHR-PB TMO DHR IDXX A IQV
Net Income $3.9B $6.34B $3.9B $0.89B $1.29B $1.37B
Inventory $0.15B $0B $0.15B $-0.03B $0.03B $0B
Dividends Paid $-0.77B $-0.58B $-0.77B $0B $-0.27B $0B
Operating Cash Flow $6.69B $8.67B $6.69B $0.93B $1.75B $2.72B
Capital Expenditure $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B $0B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 106.28
ACRS Aclaris Therapeutics, Inc. 1.34
ADVB Advanced Biomed Inc. Common Stock 1.81
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.8471
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.539
BIAF bioAffinity Technologies, Inc. 0.499
BIAFW bioAffinity Technologies, Inc. 0.1711
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 4.3
BNR Burning Rock Biotech Limited 2.84
CDNA CareDx, Inc 18.48
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.79
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 114.66
CSTL Castle Biosciences, Inc. 20.63
DGX Quest Diagnostics Incorporated 173.76
Unlock